Label: METHOCARBAMOL tablet
- NDC Code(s): 80175-0534-3
- Packager: Central Packaging
- This is a repackaged label.
- Source NDC Code(s): 31722-534
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated February 26, 2021
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
-
INDICATIONS & USAGE
Methocarbamol tablets USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of methocarbamol has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
METHOCARBAMOL
methocarbamol tabletProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:80175-0534(NDC:31722-534) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength METHOCARBAMOL (UNII: 125OD7737X) (METHOCARBAMOL - UNII:125OD7737X) METHOCARBAMOL 750 mg Product Characteristics Color white Score no score Shape OVAL Size 19mm Flavor Imprint Code 115;H Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:80175-0534-3 30 in 1 BOTTLE; Type 0: Not a Combination Product 03/20/2013 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA090200 03/20/2013 Labeler - Central Packaging (117617671) Establishment Name Address ID/FEI Business Operations Central Packaging, LLC 117617671 repack(80175-0534)
